Oncology & Cancer

Treatment for lupus enters phase III

Lupuzor may become the first specific and non-immunosuppressant therapy for lupus, a disabling autoimmune disease that is currently incurable. Discovered by Sylviane Muller's team in the CNRS Immunopathologie et Chimie Thérapeutique ...

Oncology & Cancer

Rare cancer responds unusually well to new treatment

Vienna, Austria: Patients with advanced gastrointestinal neuroendocrine tumours (NETs) have limited treatment options and there are few oncologists who are specialised in this relatively rare disease. But now results from ...

Oncology & Cancer

Clinical trial results for cancer drugs often not published

(HealthDay)—Although the U.S. Food and Drug Administration Amendments Act requires publication of the results of completed trials of cancer drugs conducted in the United States, results for almost half of the studies have ...

page 2 from 10